Shares of CVS Health Corp CVS have lost more than 2.65 percent over the past five trading days. This, the Vetr crowd seems to believe, has unlocked some room for upside, as evidenced by its average price target of $94.49, which implies a potential return of almost 8.7 percent from current valuations.
Related Link: Here's How Crowdsourced Ratings Can Beat The Market
Seeking to better reflect the larger upside potential, the Vetr community upgraded its rating on shares of CVS Health Corp on Monday, from 3.0 Stars (Hold) to 4.0 Stars (Buy) – out of a possible 5 Stars rating.
It should be noted that, in accordance with the current score and price target, 83 percent of the crowd’s ratings are bullish at the time.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.